NEW YORK (GenomeWeb News) – Qiagen today announced changes to its Maryland operations with the consolidation of three facilities into two and a $10 million investment into the businesses.

As part of the changes, Qiagen will shutter its Gaithersburg manufacturing facility and move it to the company's Germantown site, which will manufacture some of Qiagen's highest volume diagnostics assays, including the digene HC2 HPV Test for cervical cancer prevention.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.